These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3826096)

  • 1. Therapy of hypercalcemia of malignancy.
    Singer FR; Fernandez M
    Am J Med; 1987 Feb; 82(2A):34-41. PubMed ID: 3826096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of malignancy-associated hypercalcemia: 1983.
    Stewart AF
    Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etidronate disodium in the management of malignancy-related hypercalcemia.
    Hasling C; Charles P; Mosekilde L
    Am J Med; 1987 Feb; 82(2A):51-4. PubMed ID: 3103436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium.
    Jacobs TP; Gordon AC; Silverberg SJ; Shane E; Reich L; Clemens TL; Gundberg CM
    Am J Med; 1987 Feb; 82(2A):42-50. PubMed ID: 3030098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.
    Meunier PJ; Chapuy MC; Delmas P; Charhon S; Edouard C; Arlot M
    Am J Med; 1987 Feb; 82(2A):71-8. PubMed ID: 3103438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a 24-hour infusion of etidronate disodium for the treatment of hypercalcemia of malignancy.
    Flores JF; Rude RK; Chapman RA; Belani CP; Chang AY; Pritchard JD; Hoff JV
    Cancer; 1994 May; 73(10):2527-34. PubMed ID: 8174049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of malignancy associated hypercalcemia].
    Tai N; Inoue D
    Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional treatment of hypercalcemia of malignancy.
    Davidson TG
    Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S8-15. PubMed ID: 11757206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravenous etidronate disodium on skeletal and calcium metabolism.
    Kanis JA; Urwin GH; Gray RE; Beneton MN; McCloskey EV; Hamdy NA; Murray SA
    Am J Med; 1987 Feb; 82(2A):55-70. PubMed ID: 3103437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etidronate disodium: a new therapy for hypercalcemia of malignancy. Proceedings of a symposium.
    Am J Med; 1987 Feb; 82(2A):1-78. PubMed ID: 3103434
    [No Abstract]   [Full Text] [Related]  

  • 12. Parenteral diphosphonates for treating malignant hypercalcemia.
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Cancer; 1981 Oct; 48(8):1922-5. PubMed ID: 6456809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of oral administration of etidronate disodium in maintaining normal serum calcium levels in previously hypercalcemic cancer patients.
    Ringenberg QS; Ritch PS
    Clin Ther; 1987; 9(3):318-25. PubMed ID: 3111705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cancer-related hypercalcemia.
    Ritch PS
    Semin Oncol; 1990 Apr; 17(2 Suppl 5):26-33. PubMed ID: 2185550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical treatment of malignant hypercalcemia].
    Eto S; Nakano Y; Okada Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of low calcium diet, mithramycin, and dichlorodimethylene bisphosphonate on humoral hypercalcemia of malignancy in nude mice transplanted with the canine adenocarcinoma tumor line (CAC-8).
    Rosol TJ; Capen CC
    J Bone Miner Res; 1987 Oct; 2(5):395-405. PubMed ID: 2971305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of clodronate and calcitonin in hypercalcemia due to malignancy.
    Ljunghall S
    Recent Results Cancer Res; 1989; 116():40-5. PubMed ID: 2527399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study Group.
    Singer FR; Ritch PS; Lad TE; Ringenberg QS; Schiller JH; Recker RR; Ryzen E
    Arch Intern Med; 1991 Mar; 151(3):471-6. PubMed ID: 1900410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone and calcium metabolism associated with malignancy. Malignancy-associated hypercalcemia.].
    Tai N; Inoue D
    Clin Calcium; 2018; 28(11):1503-1508. PubMed ID: 30374007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalcemia of malignancy: diagnosis and therapy.
    Fetchick DA; Mundy GR
    Compr Ther; 1986 Aug; 12(8):27-32. PubMed ID: 2943551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.